IMVT - Immunovant Inc Stock Price, Fair Value and News

$25.86+0.20 (+0.78%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

IMVT Price Action

Last 7 days

-1.6%

Last 30 days

-1.2%

Last 90 days

-11.5%

Trailing 12 Months

-33.9%

IMVT RSI Chart

IMVT Valuation

Market Cap

3.8B

Price/Earnings (Trailing)

-11.75

EV/EBITDA

-10.31

Price/Free Cashflow

-13.94

MarketCap/EBT

-11.76

IMVT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

IMVT Fundamentals

IMVT Earnings

Earnings (TTM)

-323.0M

Earnings Growth (Yr)

-86.01%

Earnings Growth (Qtr)

-25.21%

IMVT Profitability

Return on Equity

-71.93%

Return on Assets

-62.63%

Free Cashflow Yield

-7.17%

IMVT Investor Care

Shares Dilution (1Y)

1.47%

Diluted EPS (TTM)

-2.21

IMVT Alerts

4 major insider sales recently.

Revenue & Growth

About Immunovant Inc

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

CEO	Dr. Peter Salzmann M.B.A., M.D.
WEBSITE	https://immunovant.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	164

Immunovant Inc Frequently Asked Questions

What is the ticker symbol for Immunovant Inc? What does IMVT stand for in stocks?

IMVT is the stock ticker symbol of Immunovant Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Immunovant Inc (IMVT)?

As of Fri Dec 20 2024, market cap of Immunovant Inc is 3.8 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IMVT stock?

You can check IMVT's fair value in chart for subscribers.

Is Immunovant Inc a good stock to buy?

The fair value guage provides a quick view whether IMVT is over valued or under valued. Whether Immunovant Inc is cheap or expensive depends on the assumptions which impact Immunovant Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IMVT.